Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05697328
NA

Barotrauma in Hyperbaric Oxygen Therapy

Sponsor: John Muir Health

View on ClinicalTrials.gov

Summary

The purpose of this research is to study whether the use of pseudoephedrine can help prevent middle ear trauma during HBOT. Pseudoephedrine is an approved drug that is used for temporary relief of nasal or sinus pain and pressure.

Official title: Pseudoephedrine Prophylaxis for Prevention of Middle Ear Barotrauma in Hyperbaric Oxygen Therapy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2023-01-31

Completion Date

2026-07

Last Updated

2025-08-27

Healthy Volunteers

No

Conditions

Interventions

DRUG

Pseudoephedrine Pill

One-time 60mg dose given orally between 45-120 minutes prior to hyperbaric oxygen therapy

DRUG

Placebo

One time dose given orally between 45-120 minutes prior to hyperbaric oxygen therapy

Locations (1)

John Muir Health

Walnut Creek, California, United States